CD274 and neoplasm: As PD-L1 expressed by cancer cells can actually inhibit antigen-specific CTLs from recognizing and killing tumor cells and even drive CTLs into apoptosis, these coated nMOFs were combined with in situ vaccination with a monoclonal antibody against PD-1.